Pharmacokinetics and tissue disposition of danofloxacin in sheep

Biopharmaceutics and Drug Disposition

Volumn 19, Issue 2, 1998, Pages 123-129

  McKellar, Quintin A ^a   Gibson, Ian F ^a   McCormack, Robert Z ^a  

^a UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Danofloxacin; Plasma pharmacokinetics; Sheep; Tissue disposition

Indexed keywords

ANTIINFECTIVE AGENT; DANOFLOXACIN; QUINOLONE DERIVATIVE;

ANIMAL EXPERIMENT; ANTIBACTERIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISPOSITION; DRUG DISTRIBUTION; DRUG HALF LIFE; DRUG METABOLISM; DRUG STABILITY; DRUG TISSUE LEVEL; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; NONHUMAN; SHEEP;

ANIMALS; ANTI-INFECTIVE AGENTS; BIOLOGICAL AVAILABILITY; BRAIN; DUODENUM; FLUOROQUINOLONES; GASTROINTESTINAL CONTENTS; ILEUM; INJECTIONS, INTRAMUSCULAR; JEJUNUM; LUNG; LYMPH NODES; QUINOLONES; SHEEP; SKIN; TIME FACTORS; TISSUE DISTRIBUTION;

EID: 0031942209     PISSN: 01422782     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1099-081X(199803)19:2<123::AID-BDD89>3.0.CO;2-G     Document Type: Article

References (26)

1. T.K. Schaaf, Proceedings of the Royal Veterinary College Symposium on Respiratory Disease in Cattle and Pigs, July 1991, p. 75.
2. P.R. McGuirk, P.R. Jefson, T.R. Shryock and T.K. Schaaf, Proceedings of the 29 Interscience Conference on Antimicrobial Agents and Chemotherapy, September 1989, p. 303.
3. J.S. Wolfson and D.C. Hooper, Antimicrob. Agents Chemother., 28, 581 (1985).
4. P.C.T. Hannan, P.J. O'Hanlon and N.H. Rogers, Res. Vet. Sci., 46, 202 (1989).
5. H.C. Neu, J. Infect. Dis., 155, 403 (1987).
6. th World Buiatrics Congress, Salvador, August 1990, p. 1189.
7. C.J. Giles, R.A. Magonigle, W.T.R. Grimshaw, A.C. Tanner, J.E. Risk, M.J. Lynch and J.R, Rice, J. Vet. Pharmacol. Ther., 14, 400 (1991).
8. C.J. Giles, Proceedings of the Royal Veterinary College Symposium on Respiratory Disease in Cattle and Pigs, July 1991, p. 87.
9. W.B. Shaw, Br. Vet. J., 127, 214 (1971).
10. H. Marsh, J. A. V. M. A., 123, 205 (1953).
11. G.E. Jones, D. Buxton and D.B. Harker, Vet. Micro., 4, 47 (1979).
12. D.A. Gill, Aust. Vet. J., 13, 46 (1937).
13. D.S. Roberts and J.R. Egerton, J. Comp. Pathol., 79, 217 (1969).
14. C.M. Metzler and D.L. Weiner, PC NONLIN Software for the Statistical Analysis on Nonlinear Models on Micros, version 4.0, Harodsburgh, Lexington, KY, 1992.
15. K. Yamaoka, T. Nakagawa and T. Uno, J. Pharmacokinet. Biopharm., 6, 165 (1978).
16. D.E. Nix, S.D. Goodwin, C.A. Peloquin, D.L. Rotella and J.J. Schentag, Antimicrob. Agents Chemother., 35, 1947 (1991).
17. D.E. Nix, S.D. Goodwin, C.A. Peloquin, D.L. Rotella and J.J. Schentag, Antimicrob. Agents Chemother., 35, 1953 (1941).
18. C.A. Peloquin, T.J. Cumbo, D.E. Nix, M.F. Sands and J.J. Schentag, Arch. Intern. Med., 149, 2269 (1989).
19. J.F. Prescott and J.D. Baggott, Antimicrobial Therapy in Veterinary Medicine, 2nd Edn., Iowa State Press, 1993, p. 234.
20. W. Hayton, V. Vlahov, N. Bacrasheva, I. Viachki, R. Portman, G. Muirhead, K. Stoeckel and E. Weigekamm, Antimicrob. Agents. Chemother., 34, 2375 (1990).
21. F. Sorgel, K.G. Naber, M. Kintzig, G. Mahr and P. Muth, Am. J. Med., 91 (suppl. 6A), S51-S66 (1991).
22. E. Rubinstein, S. Dautrey, R. Farinoti, L. St. Julien, J. Ramon and C. Carbon, Antimicrob. Agents Chemother., 39, 99 (1995).
23. E. Rubinstein, L. St. Julien, J. Ramon, S. Dautrey, R. Farinotti, J.-F. Huneau and C. Carbon, J. Infect. Dis., 169, 218 (1994).
24. U. Jachde, T. Goto, A.G. de Boer and D.D. Breiner, Eur. J. 'Pharm. Sci., l, 49 (1993).
25. H.P. Bassaris, N. Papadakis, C. Gogos and D. Simaplis. In Proceedings of the 1st Ciprofloxacin Workshop Leverkusen, H.C. Neu and H. Wenta (Eds), Exerpta Medica, Amsterdam, 1986, p. 204.
26. M. Wolff, L. Boutron, E. Singlas, B. Clair, J.M. Decazes and B. Regnier, Antimicrob. Agents Cliemother., 31, 899 (1987).